EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait

Lisa M Shook iD, Deidra Haygood, Charles T Quinn iD

International Journal of Neonatal Screening · 07.02.2025 · 11 (1) · 12

DOI: 10.3390/ijns11010012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 07.02.2025. Verfasst von Lisa M Shook und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ohio Department of Health, Association of Public Health Laboratories, Association of Public Health Laboratories Quality Improvement cohort.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemoglobinopathies are commonly detected by newborn screening (NBS). One of the most difficult to accurately diagnose is alpha-thalassemia, which is indicated by the presence of hemoglobin (Hb) Barts on NBS. This mixed methods study incorporated (1) an implementation and quality improvement project to demonstrate the clinical utility of genetic testing added to standard procedures for likely alpha-thalassemia trait and (2) a qualitative study to determine the related educational needs of primary care providers (PCPs). During a two-year period, we attempted to perform alpha-globin genetic testing for all newborns with an abnormal NBS result (an “FA + Barts” pattern). We conducted semi-structured interviews with seven PCPs for thematic abstraction. In sixty neonates with presumed Hb Barts on initial NBS who had genetic testing, three (5%) did not have alpha-thalassemia. The remaining 57 (95%) had an alpha-thalassemia trait genotype. Non-deletion alpha-thalassemia occurred in 5%. Eight (13%) had genotypes that substantially altered genetic counseling for the individual and family members. Race and ethnicity were poor surrogates for genotype. PCPs expressed a willingness to participate in NBS follow up but had little specific knowledge about alpha-thalassemia. The addition of genetic testing for likely alpha-thalassemia trait to NBS had very high clinical utility, supporting its use in standard clinical care. Whenever possible, education and genetic counseling should not be provided based on the detection of possible Hb Barts alone without subsequent specific genetic verification. Educational and outreach programs for both PCPs and families about the importance of testing and trait counseling are needed for ongoing improvement.

Schlagwörter

Stichwörter der Autor:innen

alpha-thalassemiagenotypinghemoglobinopathies

Autor:innen und Institutionen

  • Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
  • Erythrocyte Diagnostic Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

ORCID-Profile: Lisa M Shook, Charles T Quinn

Förderung

  • Ohio Department of Health
  • Association of Public Health Laboratories
  • Association of Public Health Laboratories Quality Improvement cohort
  • Ohio Department of Health Regional Sickle Cell Services Program

Zitieren

APA

Shook, L. M., Haygood, D., & Quinn, C. T. (2025). Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait. International Journal of Neonatal Screening, 11(1), 12. https://doi.org/10.3390/ijns11010012

Vancouver

Shook LM, Haygood D, Quinn CT. Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait. International Journal of Neonatal Screening. 2025;11(1):12. doi:10.3390/ijns11010012

BibTeX
@article{Shook2025,
  author = {Shook, Lisa M and Haygood, Deidra and Quinn, Charles T},
  title = {Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait},
  journal = {International Journal of Neonatal Screening},
  year = {2025},
  volume = {11},
  number = {1},
  pages = {12},
  doi = {10.3390/ijns11010012}
}
Kostenlos starten →